Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00110006 ·Status: WITHDRAWN ·Phase: NA

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

NCT01410630 ·Status: COMPLETED

Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

NCT00534989 ·Status: COMPLETED ·Phase: NA

A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation

NCT00847509 ·Status: COMPLETED ·Phase: NA

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

NCT01004718 ·Status: COMPLETED ·Phase: NA

Positron Emission Tomography(PET) in Lymphoma Assessment

NCT00887718 ·Status: COMPLETED ·Phase: NA

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

NCT01065805 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)

NCT01308905 ·Status: UNKNOWN ·Phase: NA

18F-FLT PET Imaging in Patients With Advanced Melanoma

NCT02891616 ·Status: TERMINATED ·Phase: PHASE1

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

NCT05096234 ·Status: TERMINATED ·Phase: PHASE1

The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

NCT00498667 ·Status: WITHDRAWN

Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma

NCT02241668 ·Status: WITHDRAWN ·Phase: NA

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

NCT00200668 ·Status: TERMINATED ·Phase: NA

PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning

NCT03286972 ·Status: TERMINATED

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

NCT02139150 ·Status: WITHDRAWN ·Phase: NA

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

NCT00707213 ·Status: TERMINATED ·Phase: PHASE1

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

NCT04252859 ·Status: TERMINATED ·Phase: PHASE2

Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

NCT00934401 ·Status: WITHDRAWN

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

NCT00775320 ·Status: TERMINATED

Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma

NCT00541424 ·Status: WITHDRAWN

Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager

NCT03561324 ·Status: WITHDRAWN ·Phase: NA

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

NCT00530179 ·Status: COMPLETED ·Phase: NA

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma

NCT00188929 ·Status: COMPLETED ·Phase: PHASE2

Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

NCT04464590 ·Status: COMPLETED